Weight loss injections approved by the FDA for chronic weight management include glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (Zepbound)
the SEMALEAN study reported a 15% reduction in visceral fat and an average weight loss of 12 kg after 6 months
Here at Clover Internal Medicine, we believe in providing the absolute patient care in sense of functionality, science and total whole body
Our preliminary trial found evidence for reduced alcohol craving in people with alcohol use disorder who completed about two months of treatment with semaglutide, relative to those in the placebo group, Hendershot says
Try choosing foods with short, recognizable ingredient lists and no added preservatives, artificial flavors, or stabilizersthink fresh or frozen produce, plain meats and fish, and simple pantry staples like olive oil, dried beans, and plain nuts
Combination therapy significantly reduced diabetes incidence to 38% ( p 0.001) and delayed disease onset by 6 weeks, with sustained protection persisting for 5 weeks after treatment cessation
